These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24118107)

  • 1. Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
    Zhou J; Chen M; Chen H; Pan W; Liao W
    Mycoses; 2014 Mar; 57(3):191-5. PubMed ID: 24118107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, antifungal susceptibility and scanning electron microscopy of a keratinolytic strain of Rhodotorula mucilaginosa: a primary causative agent of onychomycosis.
    da Cunha MM; dos Santos LP; Dornelas-Ribeiro M; Vermelho AB; Rozental S
    FEMS Immunol Med Microbiol; 2009 Apr; 55(3):396-403. PubMed ID: 19170752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed Infection of Toe Nail Caused by Trichosporon asahii and Rhodotorula mucilaginosa.
    Idris NFB; Huang G; Jia Q; Yuan L; Li Y; Tu Z
    Mycopathologia; 2020 Apr; 185(2):373-376. PubMed ID: 31760556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular identification, biofilm formation and antifungal susceptibility of Rhodotorula spp.
    Gharaghani M; Taghipour S; Zarei Mahmoudabadi A
    Mol Biol Rep; 2020 Nov; 47(11):8903-8909. PubMed ID: 33130966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates.
    Nunes JM; Bizerra FC; Ferreira RC; Colombo AL
    Antimicrob Agents Chemother; 2013 Jan; 57(1):382-9. PubMed ID: 23114761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
    Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA; Castanheira M; Messer SA; Jones RN
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds].
    Manzano-Gayosso P; Méndez-Tovar LJ; Arenas R; Hernández-Hernández F; Millán-Chiu B; Torres-Rodríguez JM; Cortés-González E; Fernández R; López-Martínez R
    Rev Iberoam Micol; 2011; 28(1):32-5. PubMed ID: 21147249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
    Swinne D; Watelle M; Nolard N
    Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Aller AI; Canton E; Castañón-Olivares LR; Chowdhary A; Cordoba S; Cuenca-Estrella M; Fothergill A; Fuller J; Govender N; Hagen F; Illnait-Zaragozi MT; Johnson E; Kidd S; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; St-Germain G; Trilles L; Turnidge J
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5898-906. PubMed ID: 22948877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychomycosis.
    Welsh O; Vera-Cabrera L; Welsh E
    Clin Dermatol; 2010 Mar; 28(2):151-9. PubMed ID: 20347657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
    Almyroudis NG; Sutton DA; Fothergill AW; Rinaldi MG; Kusne S
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2587-90. PubMed ID: 17452481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new species, Aspergillus persii, as an agent of onychomycosis.
    Zotti M; Machetti M; Perotti M; Barabino G; Persi A
    Med Mycol; 2010 Jun; 48(4):656-60. PubMed ID: 20055738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
    Rosa PD; Heidrich D; Corrêa C; Scroferneker ML; Vettorato G; Fuentefria AM; Goldani LZ
    Mycoses; 2017 Sep; 60(9):616-622. PubMed ID: 28657120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species identification, antifungal susceptibility profiles and biofilm formation attributes of Rhodotorula isolates from ocular infections.
    Ahmed NH; Xess I; Singh G; Satpathy G; Sharma N; Agarwal T; Hussain T; Chawla R; Tandon R
    Mycoses; 2021 Oct; 64(10):1183-1196. PubMed ID: 34228832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
    Silvanose CD; Bailey TA; Di Somma A
    Vet Rec; 2006 Aug; 159(9):282-4. PubMed ID: 16946311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of non dermatophyte onychomycosis ant its relevance for treatment].
    Monod M; Lurati M; Baudraz-Rosselet F
    Rev Med Suisse; 2013 Apr; 9(380):730-3. PubMed ID: 23621043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central venous catheter infection with Rhodotorula minuta in a patient with AIDS taking suppressive doses of fluconazole.
    Goldani LZ; Craven DE; Sugar AM
    J Med Vet Mycol; 1995; 33(4):267-70. PubMed ID: 8531026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.